KTTA

Pasithea Therapeutics Corp

May 18 • 04:00PM ET

0.7700

-0.0101 -1.29 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP NERV ADIL ALZN DMAC

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.07	Insider Own	12.28%	Shs Outstand	24.94M	Perf Week	-2.68%
Market Cap	19.21M	Forward P/E	-	EPS next Y	-2.10	Insider Trans	6.98%	Shs Float	22.10M	Perf Month	3.72%
Enterprise Value	-31.29M	PEG	-	EPS next Q	-0.45	Inst Own	70.48%	Short Float	1.21%	Perf Quarter	11.16%
Income	-19.73M	P/S	-	EPS this Y	36.08%	Inst Trans	27.83%	Short Ratio	0.65	Perf Half Y	9.53%
Sales	0.00M	P/B	0.35	EPS next Y	-12.90%	ROA	-55.58%	Short Interest	0.27M	Perf YTD	-40.31%
Book/sh	2.20	P/C	0.38	EPS next 5Y	7.54%	ROE	-58.22%	52W High	2.06 -62.62%	Perf Year	-19.46%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.00%	52W Low	0.28 174.02%	Perf 3Y	-88.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.12% 7.45%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	71.88%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	35.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.16	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	35.40	EPS Q/Q	92.68%	SMA20	0.98%	Beta	0.25	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-0.04%	Rel Volume	0.20	Prev Close	0.78
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-5.69%	Avg Volume	413.18K	Price	0.77
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	81,929	Change	-1.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)